| Literature DB >> 34244807 |
Brigid K Grabert1,2, Rachel Kurtzman1,2, Jennifer Heisler-MacKinnon2, Jennifer Leeman1,3, Adam Bjork4,5, Maddy Kameny6, Amy Liu7, Karen Todd8, Susan Alton Dailey2, Kevin Smith9, Noel T Brewer1,2, Melissa B Gilkey1,2.
Abstract
Many US health departments (HDs) conduct in-person quality improvement (QI) coaching to help primary care clinics improve their HPV vaccine delivery systems and communication. Some HDs additionally conduct remote communication training to help vaccine prescribers recommend HPV vaccination more effectively. Our aim was to compare QI coaching and communication training on key implementation outcomes. In a cluster randomized trial, we offered 855 primary care clinics: 1) QI coaching; 2) communication training; or 3) both interventions combined. In each trial arm, we assessed adoption (proportion of clinics receiving the intervention), contacts per clinic (mean number of contacts needed for one clinic to adopt intervention), reach (median number of participants per clinic), and delivery cost (mean cost per clinic) from the HD perspective. More clinics adopted QI coaching than communication training or the combined intervention (63% vs 16% and 12%, both p < .05). QI coaching required fewer contacts per clinic than communication training or the combined intervention (mean = 4.7 vs 29.0 and 40.4, both p < .05). Communication training and the combined intervention reached more total staff per clinic than QI coaching (median= 5 and 5 vs 2, both p < .05), including more prescribers (2 and 2 vs 0, both p < .05). QI coaching cost $439 per adopting clinic on average, including follow up ($129/clinic), preparation ($73/clinic), and travel ($69/clinic). Communication training cost $1,287 per adopting clinic, with most cost incurred from recruitment ($653/clinic). QI coaching was lower cost and had higher adoption, but communication training achieved higher reach, including to influential vaccine prescribers. © Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: Cancer prevention; Human papillomavirus vaccine; IQIP; Implementation science; Physician communication; Quality improvement
Mesh:
Substances:
Year: 2022 PMID: 34244807 PMCID: PMC8919808 DOI: 10.1093/tbm/ibab071
Source DB: PubMed Journal: Transl Behav Med ISSN: 1613-9860 Impact factor: 3.626